Purvisha Patel, MD, is a board-certified dermatologist and founder of Advanced Dermatology & Skin Cancer Associates in Memphis and Visha Skincare. Deeptej Singh, MD, is a board-certified dermatologist ...

Please provide your email address to receive an email when new articles are posted on . More than 50% patients only try a rosacea treatment for 2 weeks despite the doctor-recommended 12 weeks.

For many women, midlife brings a new sense of self-assurance, but it can also bring unexpected changes in skin health. One of the most frustrating and often misunderstood conditions that tends to ...

Do you feel like you’re always blushing or breaking out in pimples? You may have rosacea, a skin condition that affects more than 16 million Americans. Fortunately, doctors have tools to help. Other ...

Even though rosacea is one of the most prevalent inflammatory skin diseases for which patients seek care in dermatology clinics, treatment options for the erythema and flushing associated with rosacea ...

Please provide your email address to receive an email when new articles are posted on . After three treatments, the effectiveness and excellent rates were 68.9% and 35.6%, respectively. Of the 16 ...

Rosacea is a dermatologic condition affecting the centrofacial region (cheeks, chin, nose, and forehead), resulting in symptoms of facial flushing, swollen bumps on the skin surface, and a burning ...

Over 5% of adults are thought to have the chronic skin condition, but far fewer than that ever seek treatment for it. Reading time 5 minutes A rosy, flushed face can be a sign of embarrassment, ...

Journey Medical Corporation has announced the launch and initial distribution of Emrosi™, a new prescription medication designed to treat inflammatory lesions of rosacea in adults. Emrosi, which ...

We tested the best cleansers for rosacea — find out which products actually helped to calm redness, hydrate skin, and prevent irritation.

FORT WORTH, Texas, Jan. 12 /PRNewswire/ -- Galderma Laboratories, L.P. today announced the availability of a new MetroGel(R) 1% Kit for the topical treatment of the inflammatory lesions of rosacea.

State Medicaid formularies demonstrate significant variability in rosacea treatment coverage, with only 10% of states offering unrestricted access to basic therapeutic options, in an analysis of ...